NYSEFinancialsLife & Health InsuranceS&P MidCap 400
$290.58
+1.62 (+0.56%)
Close of Nov 06, 2026 · end-of-day data
PRI 8-K filings in 2025
Every material Form 8-K Primerica filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Primerica reported third-quarter 2025 results with total revenues of $839.9 million, up 8% from a year earlier, and net income of $206.8 million, up 6% from continuing operations in the prior-year period. Investment and Savings Products sales reached $3.7 billion, the highest quarterly result in the company's history, but Term Life policies issued fell 15%, and recruits fell 29%, which bears on future sales capacity.
Diluted EPS was $6.35, up 11% from $5.72; diluted adjusted operating EPS was $6.33, up 11% from $5.68.
Investment and Savings Products sales rose 28% to $3.7 billion, and average client asset values rose 14% to $123.1 billion.
Term Life issued 79,379 new policies, down 15%, and recruits fell 29% to 101,156 compared with the prior-year period.
The company repurchased $129 million of common stock in the quarter and declared a $1.04 per share dividend payable December 15, 2025.
Primerica reported second-quarter 2025 results, with total revenue of $793.3 million and GAAP diluted EPS of $5.40, down from $6.07 from continuing operations a year earlier. Adjusted diluted operating EPS rose 10% to $5.46, but the year-earlier GAAP figure included a $50 million insurance claim gain that the company excludes from its adjusted measures.
Total revenue was $793.3 million versus $791.0 million in Q2 2024; net income was $178.3 million.
Diluted adjusted operating EPS was $5.46, up 10% from $4.95; adjusted operating revenues rose 7% to $796.0 million.
Term Life adjusted direct premiums rose 5%; ISP product sales were $3.5 billion, up 15%.
The company repurchased $129 million of common stock and declared a $1.04 per share dividend payable September 15, 2025.
Primerica reported first-quarter 2025 results on May 7, 2025, with total revenues of $804.8 million, up 9%, and diluted earnings per share of $5.05, up 19% from continuing operations in the prior-year period. Growth was driven mainly by its Investment and Savings Products segment, while its Term Life segment benefited from a stable in-force policy block, and the company also repurchased $118 million of common stock.
Total revenues were $804.8 million, up 9% from the first quarter of 2024.
Net income was $169.1 million, up 14% versus continuing operations in the prior-year period; diluted EPS was $5.05, up 19%.
Diluted adjusted operating EPS was $5.02, up 20% from the first quarter of 2024.
The company repurchased $118 million of common stock and declared a dividend of $1.04 per share, payable June 13, 2025, to holders of record on May 22, 2025.
Primerica reported fourth-quarter 2024 results with total revenues of $788.1 million, up 12%, and net income from continuing operations of $167.7 million, up 9%. Diluted earnings per share from continuing operations rose 14% to $4.98, and the company raised its quarterly dividend 16% to $1.04 per share, which matters to shareholders because it reflects higher profit per share and added capital returned to them.
Diluted adjusted operating earnings per share were $5.03, up 17%; full-year 2024 diluted EPS from continuing operations was $20.99, up 28%
Investment and Savings Products sales rose 41% to $3.3 billion; client asset values reached a record $112.1 billion
Board approved a new $450 million share repurchase program through December 31, 2025, after $44.4 million of Q4 buybacks
Dividend of $1.04 per share is payable March 14, 2025, to holders of record on February 21, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Primerica filing is on SEC EDGAR ↗. 8-K briefs of other companies →